Purpose: to study the effect of immunosupressive therapy (IST) in the virus-negative and virus-positive patients with immune-mediated myocarditis.

Methods: in 60 patients (45 male, 46.7 ± 11.8 years, mean LV EDD, 6.7 ± 0.7 cm, EF 26.2 ± 9.1%) active/borderline myocarditis was verified by endomyocardial biopsy (n = 38), intraoperative biopsy (n = 10), examination of explanted heart (n = 3) and autopsy (n = 9). Indications for IST determined based on histological, immune activity. The follow-up was 19.0 [7.25; 40.25] months.

Results: The viral genome in the myocardium was detected in 32 patients (V+ group), incl. parvovirus B19 in 23. The anti-heart antibody level was equally high in the V+ and V- patients. Antiviral therapy was administered in 24 patients. IST (in 22 V+ and 24 V- patients) include steroids (n = 40), hydroxychloroquine (n = 20), azathioprine (n = 21). The significant decrease of LV EDD (6.7 ± 0.7 to 6.4 ± 0.8), PAP (48.9 ± 15.5 to 39.4 ± 11.5 mm Hg, р<0,01), increase of EF (26.5 ± 0.9 to 36.0 ± 10.8), and lower lethality (23.9% and 64.3%; RR 0.37, 95% CI 0.19-0.71), p<0.01, were found only in IST group. Significant improvement due to IST were achieved not only in V-, but also in V+ patients.

Conclusions: IST in patients with immune-mediated lymphocytic myocarditis is effective and is associated with lower lethality both in virus-negative and virus-positive patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carpath.2020.107260DOI Listing

Publication Analysis

Top Keywords

virus-negative virus-positive
8
virus-positive patients
8
patients
7
immunosuppressive therapy
4
therapy biopsy
4
biopsy proved
4
proved immune-mediated
4
immune-mediated lymphocytic
4
lymphocytic myocarditis
4
myocarditis virus-negative
4

Similar Publications

Background: Respiratory syncytial virus vaccines first recommended for use during 2023 were efficacious against lower respiratory tract disease in clinical trials. Limited real-world data regarding respiratory syncytial virus vaccine effectiveness are available. To inform vaccine policy and address gaps in evidence from the clinical trials, we aimed to assess the effectiveness against respiratory syncytial virus-associated hospitalisations and emergency department encounters among adults aged at least 60 years.

View Article and Find Full Text PDF
Article Synopsis
  • Trichomonas vaginalis (Tvag) is a sexually transmitted pathogen linked to five strains of Trichomonas vaginalis viruses (TVVs), which are typically passed directly from mother to daughter cells without an extracellular phase in their lifecycle.* -
  • A nucleoside analog called 2'-C-methylcytidine (2CMC) has been found effective in clearing infections from various TVV strains, including TVV1, TVV2, and TVV3, and newly confirmed to also clear TVV4 and TVV5.* -
  • The study revealed differences in drug susceptibility among TVV species, allowing for the creation of genetically similar Tvag clones with various TVV combinations, which may
View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide including sub-Saharan Africa. The GALAD score, derived from Gender, Age, Lens culinaris agglutinin-reactive fraction of alpha fetoprotein, Alpha fetoprotein, and Des-carboxy-prothrombin, has high accuracy in diagnosing HCC in Asia, Europe, and North America; however, it has not been validated in an African cohort. The aim of this study was to assess the performance of the GALAD score in the diagnosis of HCC in sub-Saharan Africa.

View Article and Find Full Text PDF

(Tvag) is a sexually transmitted human pathogen that is commonly infected with strains of one or more of five known species of Trichomonas vaginalis viruses (TVVs), members of genus . TVVs are thought not to have an extracellular phase to their lifecycle and instead to be transmitted vertically from mother to daughter cells. As a result, generation of isogenic virus-positive and virus-negative sets of Tvag clones has been a major barrier to study interactions between TVVs and their host.

View Article and Find Full Text PDF
Article Synopsis
  • * In a study measuring cytokine levels in 158 pediatric kidney and liver transplant patients, higher levels of IL-4, IL-8, and IL-10 were found to be associated with graft rejection, especially in cases with certain herpesviruses present.
  • * The research stresses the need for closer monitoring of not just EBV and HCMV, but also HHV6 and HHV7 to improve risk assessment and treatment strategies for pediatric transplant patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!